NEWS & PERSPECTIVES

Psychedelics News

Curated updates on microdosing, research, policy, and community.

The latest

2026-08-05 • Psychedelic Invest

Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003

CAMBRIDGE, Mass., August 05, 2026--Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address…

2026-08-05 • Psychedelic Invest

Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights

LONDON & NEW YORK, August 05, 2026--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, today reported the…

2026-08-04 • Medical Xpress (Psychedelics)

New 'Medicine 4.0' framework calls for greater access to both ideas and services

Modern medicine has become increasingly focused on preventing disease and extending healthy life, but a new paper claims that the next major leap in health care will require something more fundamental: ensuring that b...

2026-08-04 • Blossom Pulse: Papers

Targeting peripheral 5-HT2AR enhances antitumor immunity in colorectal cancer

This preclinical study found that LSD and the non-brain-penetrant analogue IHCH-8110 enhanced antitumour immune responses in colorectal cancer models. Activating peripheral serotonin 5-HT2A receptors promoted CD8+ T-c...

2026-08-03 • Psychedelics Today

Weekly Psychedelic Policy Briefing – August 2, 2026

The House attached psychedelic amendments to the FY2027 defense bill, VA Secretary Doug Collins promoted the agency's 20 active trials, and Louisiana began spending opioid settlement money on psychedelic research, wit...

2026-08-03 • Psychedelic Invest

Definium Therapeutics Announces New Employee Inducement Grants

NEW YORK, August 03, 2026--Definium Therapeutics, Inc. ("Definium" or the "Company"), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address…

2026-08-03 • The Microdose (Berkeley)

The psychedelic toad milkers

Following toad poachers across the Sonoran Desert

2026-08-03 • DoubleBlind Magazine

Horizons and Its Psychedelic Circus Are Back in NYC This Fall

PLUS, meeting your soulmate in ceremony, music in psychedelic therapy, and mushrooms in India [...] Read More... The post Horizons and Its Psychedelic Circus Are Back in NYC This Fall appeared first on DoubleBlind Mag.

2026-08-03 • Blossom Pulse: Papers

Psychological change processes in alcohol use disorder: A qualitative study of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) with cognitive behavioural therapy

This qualitative study (n=10 participants, six therapists) explored psychological changes after a single intranasal dose of 5-MeO-DMT alongside psychological support and cognitive behavioural therapy for alcohol use d...

2026-08-02 • The Psychedelic Blog (Substack)

The Psychedelic Red Flags I Never Ignore

This Week's Sunday Insider: The warning signs I never ignore.

2026-08-02 • Blossom Pulse: Papers

Safety and Efficacy of Psilocybin During Anticancer Treatment: A Phase II Trial Secondary Analysis

This open-label Phase II secondary analysis (n=30) compared psilocybin-assisted therapy in people with cancer receiving systemic anticancer treatment and those who were not. A single 25-mg dose produced similar reduct...

2026-08-01 • Ecstatic Integration

Homer on drugs

Drugs in The Odyssey are typically foreign, female-facilitated, and a potential threat to male identity and virtue. But not always.

2026-08-01 • Blossom Pulse: Papers

Ketamine assisted psychotherapy to reduce chronic neuropathic pain: A mixed-methods randomized pilot trial

This randomised, outcome-assessor-blinded pilot trial (n=30) assessed intravenous ketamine, psychotherapy, or their combination for adults with moderate-to-severe chronic neuropathic pain. Combining ketamine with psyc...

2026-08-01 • Blossom Pulse: Papers

Brain iron-sensitive markers (magnetic susceptibility and R2*) predict antidepressant response to ketamine in treatment-resistant depression

This analysis (n=17) of a double-blind randomised placebo-controlled trial and subsequent open-label study examined whether brain iron-sensitive MRI measures predicted response to repeated intravenous ketamine in peop...

2026-07-31 • Psychedelics Today

Mareesa Stertz – Sphinx Gate Beyond Burning Man: Psychedelic Healing Without Psychedelics

Mareesa Stertz returns to discuss how Sphinx Gate is evolving beyond Burning Man into a portable rite of passage. She and Joe explore storytelling, embodiment, psychedelic community, self-trust, and becoming more huma...